TLR7 Agonist

TLR7 Agonists (37):

Cat. No.	Product Name	Effect	Purity

HY-13740

Resiquimod	Agonist	99.96%
Resiquimod is a Toll-like receptor 7 and 8 (TLR7/TLR8) agonist that induces the upregulation of cytokines such as TNF-α, IL-6 and IFN-α.

HY-109104

Telratolimod	Agonist	98.98%
Telratolimod (MEDI9197) is a potent toll like receptors 7/8 (TLR7/8) agonist, with antitumor activity.

HY-B0180

Imiquimod	Agonist	99.96%
Imiquimod (R 837), an immune response modifier, is a selective toll like receptor 7 (TLR7) agonist.

HY-103698

TLR7/8 agonist 1	Agonist
TLR7/8 agonist 1 is a toll-like receptor (TLR7)/TLR8 dual-agonistic imidazoquinoline.

HY-13740G

Resiquimod (GMP)	Agonist
Resiquimod (R848) (GMP) is Resiquimod (HY-13740) produced by using GMP guidelines.

HY-153072

TLR7 agonist 7	Agonist
TLR7 agonist 7 (compound IIb-26) is an TLR7 agonist with an EC₅₀ value of ~4 nM.

HY-B0180A

Imiquimod hydrochloride	Agonist	99.80%
Imiquimod hydrochloride (R 837 hydrochloride), an immune response modifier, is a selective toll like receptor 7 (TLR7) agonist.

HY-111786

LHC-165	Agonist	≥98.0%
LHC-165 is a TLR7 agonist.

HY-110120

DSR-6434	Agonist	98.33%
DSR-6434 is a potent and selective Toll-like receptor 7 (TLR7) agonist, with EC₅₀s of 7.2 nM and 4.6 nM for human and mice TLR7, respectively.

HY-103697A

Gardiquimod diTFA	Agonist	≥99.0%
Gardiquimod diTFA, an imidazoquinoline analog, is a TLR7/8 agonist.

HY-118250

GSK2245035	Agonist	99.84%
GSK2245035 is a highly potent and selective intranasal Toll-Like receptor 7 (TLR7) agonist with preferential Type-1 interferon (IFN)-stimulating properties.

HY-130797

TLR7/8 agonist 3	Agonist	99.02%
TLR7/8 agonist 3 is a potent TLR7 and TLR8 agonist, extracted from patent WO2016057618 (compound of formula (II)).

HY-115400

1V209	Agonist	99.59%
1V209 (TLR7 agonist T7) is a Toll-like receptor 7 (TLR7) agonist and has anti-tumor effects.

HY-111269

AZD8848	Agonist	98.08%
AZD8848 is a selective toll-like receptor 7 (TLR7) antedrug agonist which is developed for the research of asthma and allergic rhinitis.

HY-108472

Loxoribine	Agonist	99.64%
Loxoribine (7-Allyl-8-oxoguanosine) is a guanosine analog with anti-viral and anti-tumor activities.

HY-128799

CL097	Agonist	99.89%
CL097, a potent TLR7 and TLR8 agonist, induces pro-inflammatory cytokines in macrophages.

HY-145960

MC-Val-Cit-PAB-Amide-TLR7 agonist 4	Agonist	99.39%
MC-Val-Cit-PAB-Amide-TLR7 agonist 4 (example 15) is a HER2-TLR7 and HER2-TLR8 immune agonist conjugate.

HY-111358

TLR7 agonist 1	Agonist	98.95%
TLR7 agonist 1 is a potent, selective and oral TLR7 agonist with an IC₅₀ of 90 nM.

HY-139017

TLR7/8 agonist 4	Agonist	99.04%
TLR7/8 agonist 4 (compound 41) is a potent TLR7/8 agonist.

HY-145961

TLR7 agonist 4	Agonist	98.87%
TLR7 agonist 4 (Compound 1.2) is a TLR7 agonist with an EC₅₀ of 4.3 nM.

Name
Email *

	Sorry, but the email address you supplied was invalid.